gadoxetic-acid-disodium and Hepatoblastoma

gadoxetic-acid-disodium has been researched along with Hepatoblastoma* in 1 studies

Reviews

1 review(s) available for gadoxetic-acid-disodium and Hepatoblastoma

Article	Year
Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation. Pediatric radiology, 2012, Volume: 42, Issue:7 Gadoxetate disodium (Gd-EOB-DTPA) is a hepatobiliary MRI contrast agent widely used in adults for characterization of liver tumors and increasingly used in children. Hepatoblastoma is the most common primary hepatic malignancy of childhood. In this review, we describe our experience with this agent both before and after initiating therapy in children with hepatoblastoma. Topics: Adult; Child; Child, Preschool; Contrast Media; Gadolinium DTPA; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Prognosis; Treatment Outcome	2012

Article

Year

Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation.

Pediatric radiology, 2012, Volume: 42, Issue:7

Gadoxetate disodium (Gd-EOB-DTPA) is a hepatobiliary MRI contrast agent widely used in adults for characterization of liver tumors and increasingly used in children. Hepatoblastoma is the most common primary hepatic malignancy of childhood. In this review, we describe our experience with this agent both before and after initiating therapy in children with hepatoblastoma.

Topics: Adult; Child; Child, Preschool; Contrast Media; Gadolinium DTPA; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Prognosis; Treatment Outcome

2012